Frank B. McGuyer
Founder at McGuyer Homebuilders, Inc.
Frank B. McGuyer active positions
Companies | Position | Start | End |
---|---|---|---|
McGuyer Homebuilders, Inc.
McGuyer Homebuilders, Inc. HomebuildingConsumer Durables McGuyer Homebuilders, Inc. builds single-family residential homes. It markets homes under the brand names Coventry Homes, Pioneer Homes and Plantation Homes. The company was founded by Frank B. McGuyer and Mike Love in 1988 and is headquartered in Houston, TX. | Founder | 01/01/1988 | - |
Chairman | 01/01/1988 | - | |
Chief Executive Officer | 01/01/1988 | - |
Career history of Frank B. McGuyer
Former positions of Frank B. McGuyer
Companies | Position | Start | End |
---|---|---|---|
BELLICUM PHARMACEUTICALS, INC. | Director/Board Member | 01/03/2009 | 20/12/2018 |
Independent Dir/Board Member | 01/03/2009 | 20/12/2018 |
Training of Frank B. McGuyer
Southern Methodist University | Undergraduate Degree |
Statistics
International
United States | 4 |
Operational
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Sectoral
Consumer Durables | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
McGuyer Homebuilders, Inc.
McGuyer Homebuilders, Inc. HomebuildingConsumer Durables McGuyer Homebuilders, Inc. builds single-family residential homes. It markets homes under the brand names Coventry Homes, Pioneer Homes and Plantation Homes. The company was founded by Frank B. McGuyer and Mike Love in 1988 and is headquartered in Houston, TX. | Consumer Durables |
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Frank B. McGuyer
- Experience